Please login to the form below
reimbursement
This page shows the latest reimbursement news and features for those working in and with pharma, biotech and healthcare.
Life science companies can’t keep up with technology competitors
To add another woe to the life science sector landscape, the number of drugs achieving at least 50% of analysts’peak sales forecasts is falling but reimbursement pressures are on the
Latest news
-
Sanofi, Regeneron offer price cut for cholesterol drug Praluent
Sanofi, Regeneron offer price cut for cholesterol drug Praluent. Amgen’s Repatha also struggled to secure reimbursement at its launch price point. ... point have struggled to secure reimbursement from healthcare payers in the US.
-
$5.76bn deal puts Merck closer to Eisai and fast-growing Lenvima
Merck is in line for $650m in option right payments, $450m reimbursement of R&D expenses, and two blocks of $385m and $3.97bn for various regulatory and sales milestones, but
-
Theratechnologies’ last-ditch HIV drug approved by FDA
The company’s chief executive Luc Tanguay has said he expects sales to build gradually as reimbursement becomes available.
-
NICE finally starts review of Biogen’s Spinraza for SMA
development of a Managed Access Agreement straight away has reassured the company that there is still a viable, long-term reimbursement path for this significant therapeutic advancement in England”.
-
Transforming access in rare diseases
Health Technology Assessment (HTA) is an essential component of the introduction and reimbursement of new medicines - not just in the United Kingdom (with bodies such as NICE, the SMC and AWMSG) - ... Within a single country, the landscape can be complex,
More from news
Approximately 45 fully matching, plus 482 partially matching documents found.
Latest Intelligence
-
Can value-based healthcare take off and reach for the skies?
costs. It was then backed with a ‘no response-no payment’contract. It has also struck novel reimbursement packages with its heart failure therapy Entresto and its psoriasis treatment Cosentyx.
-
Digital health
The shift in focus to reimbursement for quality and outcomes has meant that physicians are more open to considering digital health to help facilitate a patient’s engagement in their own ... With digital health, the R&D path is completely different; the
-
Drug pricing
Healthcare terms - Drug pricing.
-
Market access
Healthcare terms - Market access.
-
The good, the bad and the ugly
Vertex’growth has been helped by obtaining reimbursement for its CFTR modulator, Orkambi, in Europe, ”says Pavan Kottamasu, analyst, cardiovascular and metabolic disorders.
More from intelligence
Approximately 12 fully matching, plus 115 partially matching documents found.
Latest appointments
-
Claes Buxfeldt joins NDA
Claes Buxfeldt joins NDA. He becomes its new HTA director. AstraZeneca’s former global price and reimbursement director Claes Buxfeldt has joined the NDA advisory board.
-
Mereo BioPharma appoints head of patient access and commercial planning
In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and led pricing, reimbursement and access teams for the group’s rare disease product portfolio.
-
W2O bolsters its commercialisation offering
with pricing and reimbursement strategy and communications.
-
Hanover Brussels appoints Aurélie Marchand as account director
Coming from a country where market access and negotiations around pricing and reimbursement can be challenging, I’m eager to bring this experience to the EU level.”.
-
McCann Health expands consulting team
Previously serving Healthcare Management Solutions as its senior director and project leader for health economics, global reimbursement and healthcare policy, Goodman’s expertise lies in public healthcare, economics and healthcare policy.
More from appointments
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest from PMHub
-
Medicines personalised for Tom, Dick and Harry
the diminished returns from small patient populations, with the gamble that reimbursement will be sanctioned due to reduced concerns of budget impact? ... In such cases, perhaps patent protection should be extended to permit adequate reimbursement to
-
Video: Self-pay and Emerging Markets
For all but the most severe conditions, public reimbursement of medication is often partial to non-existent, particularly in the outpatient setting.
-
Global Corporate Divestment Study
Expiring patents along with regulatory and reimbursement changes were significant divestment drivers.
-
Understanding Patient Willingness to Pay
For all but the most severe conditions, public reimbursement of pharmaceutical products and personal medical devices is often partial to non-existent, particularly in the outpatient setting.
-
Navigating the way to a positive HTA: avoiding snakes, climbing ladders
Health technology assessment (HTA) outcomes can make, or break, a product’ s fate; depending on the HTA body’ s remit, outcome decisions can affect a technology’ s reimbursement status or position
More from PMHub
Approximately 0 fully matching, plus 50 partially matching documents found.
Featured jobs
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Scientific Director
-
Great salary and bebefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Account Manager – Med Comms – London
-
Salary TBC
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
-
Senior Programme Executive
-
Salary TBC
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Senior Medical Writer
-
Great salary and bebefits
Subscribe to our email news alerts
- BenevolentAI raises $115m to fund drug development
- Shire rebuffs Takeda bids, as Allergan bows out
- Abeona Therapeutics names CEO
- Zelluna Immunotherapy appoints chief technology officer
- Spirit Health Group offers new market access consultancy service
- Why heading online for scientific meetings can yield greater HCP engagement
PMHub
Digitas Health
Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....
Latest intelligence
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Quick links
Infographics
